Brooks Laboratories P/E Ratio
Current P/E Ratio
14.16
Low Valuation
Low - May indicate good value opportunity
Brooks Laboratories (BROOKS) P/E ratio is 14.16 (Low), EPS (TTM) ₹8.35, current price ₹61.53 on NSE — Low - May indicate good value opportunity.
Current Valuation Metrics
P/E Ratio
14.16
Current Price
₹61.53
EPS (TTM)
₹8.35
Exchange
NSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
57.01
Sector Median
32.06
Sector Rank
#11 of 199
Sector Percentile
5.5%
Earnings Breakdown (TTM)
TTM EPS
₹2.08
Mar 2026
₹0.52
Jun 2026
₹-0.61
BROOKS P/E Ratio — Valuation Signal & Historical Context
Brooks Laboratories P/E 14.16 — signal: Fairly Valued. For live price, revenue and the complete fundamental profile, see BROOKS screener.
- Stock appears undervalued with PE of 14.16, suggesting potential buying opportunity
- Trading at discount to sector average PE of 57.01
BROOKS vs Healthcare Peers — P/E Ratio Comparison
Brooks Laboratories P/E 14.16 vs Healthcare average 57.01, median 32.06 — range 1.99–747.21.
Sector Average
57.01
Sector Median
32.06
Lowest P/E
1.99
Highest P/E
747.21
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |